>
Switch to:

Tekla Life Sciences Investors Stock Based Compensation

: $0.0 Mil (TTM As of Sep. 2020)
View and export this data going back to . Start your Free Trial

Tekla Life Sciences Investors's Stock Based Compensation for the six months ended in Sep. 2020 was $0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Sep. 2020 was $0.0 Mil.


Tekla Life Sciences Investors Stock Based Compensation Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Tekla Life Sciences Investors Annual Data
Sep17 Sep18 Sep19 Sep20
Stock Based Compensation 0.00 0.00 0.00 0.00

Tekla Life Sciences Investors Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20
Stock Based Compensation Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Tekla Life Sciences Investors Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

For stock reported semi-annually, GuruFocus uses latest annual data as the TTM data. Stock Based Compensation for the trailing twelve months (TTM) ended in Sep. 2020 was $0.0 Mil.


Tekla Life Sciences Investors Stock Based Compensation Related Terms


Tekla Life Sciences Investors Stock Based Compensation Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)